The Ludwig Institute for Cancer Research Ltd (LICR)is a global non profit committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

Dr. Villa (former Director, LICR São Paulo Branch) and her colleagues led the first study to show clinical efficacy of the cervical cancer vaccine, Gardasil®. Dr. Villa has spent decades studying the relationship between human papillomavirus (HPV) infection and cervical cancer; data that contributed substantially to the development of the cervical cancer vaccine. More »